SAVANNAH, GA Saying she hoped to find a similar opportunity in a more desirable location, area woman Kristy Molloy reportedly rejected a lifestyle that 95% of the global population will never achieve Thursday when she turned down a job in Toledo, OH. “I guess I always pictured myself living in a place with a bit more…
The National Institute for Health and Care Excellence announced final draft guidance recommending the PARP inhibitor olaparib for patients with HER2-negative, high-risk early breast cancer harboring a BRCA1/2 mutation, as well as for those with previously treated hormone-relapsed metastatic prostate cancer with a BRCA1/2 mutation.